Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Viktoria Sjöblom |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding / Pär Hallberg en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 1 (Febrero)
[artículo]
Título : The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding : A review and clinical aspects Tipo de documento: texto impreso Autores: Pär Hallberg, Autor ; Viktoria Sjöblom, Autor Fecha de publicación: 2023 Artículo en la página: pp. 59-73 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Lactancia materna, Intercambio materno-fetal, Atención posnatal, Embarazo, Complicaciones del embarazo, Inhibidores selectivos de la recaptación de serotonina Resumen: Mood and anxiety disorders are common in women during their childbearing years. The prevalence of depression has been reported to be between 10% and 16% during pregnancy. The use of selective serotonin reuptake inhibitors during pregnancy or lactation is, to date, not promoted because of lack of safety documentation. Link: ./index.php?lvl=notice_display&id=30927
in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 1 (Febrero) . - pp. 59-73[artículo] The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding : A review and clinical aspects [texto impreso] / Pär Hallberg, Autor ; Viktoria Sjöblom, Autor . - 2023 . - pp. 59-73.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 1 (Febrero) . - pp. 59-73
Palabras clave: Lactancia materna, Intercambio materno-fetal, Atención posnatal, Embarazo, Complicaciones del embarazo, Inhibidores selectivos de la recaptación de serotonina Resumen: Mood and anxiety disorders are common in women during their childbearing years. The prevalence of depression has been reported to be between 10% and 16% during pregnancy. The use of selective serotonin reuptake inhibitors during pregnancy or lactation is, to date, not promoted because of lack of safety documentation. Link: ./index.php?lvl=notice_display&id=30927